Get the Stockscreener App
223.55
1.21%
2.67
Pre-market:
222.57
-0.98
-0.44%
Iqvia Holdings Inc stock is traded at $223.55, with a volume of 2.41M.
It is up +1.21% in the last 24 hours and up +9.71% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$220.88
Open:
$218.7
24h Volume:
2.41M
Relative Volume:
1.66
Market Cap:
$38.00B
Revenue:
$15.90B
Net Income/Loss:
$1.28B
P/E Ratio:
30.69
EPS:
7.2842
Net Cash Flow:
$2.21B
1W Performance:
+6.02%
1M Performance:
+9.71%
6M Performance:
+48.36%
1Y Performance:
+5.69%
1-Day Range:
$217.61
$228.12
1-Week Range:
$206.72
$228.12
52-Week Range:
$134.65
$228.12
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
223.55 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
580.13 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.20 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.48 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.89 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
Is IQVIA Holdings Inc. stock positioned for digital transformationMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
Is IQVIA Holdings Inc. stock near bottom after decline2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Why IQVIA Holdings Inc. stock is rated strong buy2025 Valuation Update & Advanced Technical Analysis Signals - newser.com
Heatmap analysis for IQVIA Holdings Inc. and competitorsMarket Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
Will IQVIA Holdings Inc. stock remain on Wall Street radarJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Why IQVIA Holdings Inc. stock is seen as undervalued2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Iqvia stock hits 52-week high at 225.07 USD By Investing.com - Investing.com UK
BMO Capital Initiates Coverage on IQVIA Holdings (IQV) with Outp - GuruFocus
BMO Capital Initiates IQVIA Holdings at Outperform With $260 Price Target - MarketScreener
Will IQVIA Holdings Inc. stock profit from fiscal stimulusJuly 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
Key metrics from IQVIA Holdings Inc.’s quarterly dataPortfolio Return Report & Technical Entry and Exit Tips - newser.com
Using Ichimoku Cloud for IQVIA Holdings Inc. technicals2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Will IQVIA Holdings Inc. stock outperform value peersForecast Cut & Expert Curated Trade Ideas - newser.com
Can IQVIA Holdings Inc. (QTS) stock deliver strong annual returnsJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com
Why IQVIA Holdings Inc. stock could break out in 2025Quarterly Market Summary & Safe Capital Growth Trade Ideas - newser.com
IQVIA Stock Surges on Strong Earnings and AI Focus - AD HOC NEWS
IQVIA Holdings Inc (IQV)'s Winning Formula: Financial Metrics an - GuruFocus
IQVIA at UBS Global Healthcare Conference: Strategic Insights on Growth By Investing.com - Investing.com South Africa
Will IQVIA Holdings Inc. stock continue upward momentum2025 Earnings Surprises & AI Driven Price Predictions - newser.com
Will IQVIA Holdings Inc. stock deliver strong dividend growthJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Will IQVIA Holdings Inc. stock outperform international peersInsider Selling & Weekly Chart Analysis and Guides - newser.com
Is IQVIA Holdings Inc. stock at risk of policy regulationWeekly Risk Summary & Community Verified Trade Signals - newser.com
Will IQVIA Holdings Inc. (QTS) stock enhance shareholder valueWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):